Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Urology. 2010 Jun;75(6):1328-34. doi: 10.1016/j.urology.2009.10.040. Epub 2010 Jan 18.
To report experience with 100 robot-assisted partial nephrectomy (RAPN) operations performed at our institution. Nephron-sparing surgery is an established treatment for patients with small renal masses. The laparoscopic approach has emerged as an alternative to open nephron-sparing surgery, but it is recognized to be technically challenging. The robotic surgical system may enable faster and greater technical proficiency, facilitating a minimally invasive approach to more difficult lesions while reducing ischemia time.
A total of 100 RAPN operations were performed for suspicious solid renal lesions during a 21-month period. Clinicopathologic variables, nephrometry scores, operative parameters, and renal functional outcomes were prospectively recorded and analyzed.
Median tumor size was 2.8 cm (range, 1.0-8). Nephrometry scores of resected lesions were low in 47.9% of patients, medium in 45.7%, and high in 6.4% of patients. Forty-seven percent of patients had tumors>50% intraparenchymal, and 61.7% had tumors located less than 7 mm away from the renal sinus or collecting system. In 17% of patients, the tumors were touching a first-order vessel in the renal hilum. Mean warm ischemia time was 25.5 minutes (range, 0-53). Mean change in postoperative glomerular filtration rate improved 6.32 mL/min/1.73 m2 (range, -41.9 to 68.9). Histology was renal cell carcinoma in 81% (87/107) of tumors. There were 5 microscopically positive margins on final pathology (5.7%). Major and minor complication rates were 6% and 5%, respectively. There were 2 conversions to open surgery.
RAPN seems to be a safe and technically feasible minimally invasive approach to nephron-sparing surgery even in more complex cases, with acceptable pathologic and renal function outcomes.
报告本机构实施的 100 例机器人辅助部分肾切除术(RAPN)的经验。保肾手术是治疗小肾肿瘤患者的一种既定治疗方法。腹腔镜技术已成为保肾手术的一种替代方法,但被认为具有技术挑战性。机器人手术系统可能使手术更快、技术更熟练,促进对更困难病变的微创方法,同时减少缺血时间。
在 21 个月期间,对疑似实体性肾病变的 100 例 RAPN 手术进行了前瞻性记录和分析。记录并分析了临床病理变量、肾肿瘤学评分、手术参数和肾功能结果。
中位肿瘤大小为 2.8cm(范围,1.0-8cm)。47.9%的患者肿瘤切除标本的肾肿瘤学评分较低,45.7%的患者评分中等,6.4%的患者评分较高。47%的患者肿瘤>50%位于肾实质内,61.7%的患者肿瘤距离肾窦或集合系统小于 7mm。在 17%的患者中,肿瘤触及肾门一级血管。平均热缺血时间为 25.5 分钟(范围,0-53 分钟)。术后肾小球滤过率平均改善 6.32ml/min/1.73m2(范围,-41.9 至 68.9ml/min/1.73m2)。组织学上 81%(87/107)的肿瘤为肾细胞癌。最终病理有 5 例肿瘤边缘阳性(5.7%)。主要和次要并发症发生率分别为 6%和 5%。有 2 例转为开放手术。
RAPN 似乎是一种安全且技术可行的微创保肾手术方法,即使在更复杂的病例中,也具有可接受的病理和肾功能结果。